TY - JOUR
T1 - A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors
AU - Petersen, S L
AU - Ryder, L P
AU - Björk, P
AU - Madsen, H O
AU - Heilmann, C
AU - Jacobsen, N
AU - Sengeløv, H
AU - Vindeløv, L L
PY - 2003/7
Y1 - 2003/7
N2 - This retrospective study compares the reconstitution of T, B and NK cells in three groups of patients transplanted for haematological malignancies with grafts from their HLA-identical sibling donors. In all, 15 patients received PBSC after a nonmyeloablative conditioning regimen consisting of fludarabine and 200 cGy TBI, 13 patients received PBSC after myeloablative conditioning and 37 patients received BM after myeloablative conditioning. In the nonmyeloablative group, the NK cells normalised after 1 month, the CD8+ T cells normalised after 3 months, the CD4+ T cells reached near normal values after 9 months and the B cell values were reduced until 12 months after transplant. In the two myeloablative groups, recipients of PBSC had a significantly higher number of CD4+ T cells after 4 months (P=0.004) and after 12 months (P=0.001), than recipients of BM. We found no differences in the T cell reconstitution between the two PBSC groups. This was of interest as the recipients of nonmyeloablative conditioning were older (P<0.001) and had a higher occurrence of chronic GVHD (P<0.05) than the recipients of myeloablative conditioning. In contrast, the recipients of nonmyeloablative conditioning had a delayed B cell recovery when compared to the patients who received myeloablative conditioning (P=0.04).
AB - This retrospective study compares the reconstitution of T, B and NK cells in three groups of patients transplanted for haematological malignancies with grafts from their HLA-identical sibling donors. In all, 15 patients received PBSC after a nonmyeloablative conditioning regimen consisting of fludarabine and 200 cGy TBI, 13 patients received PBSC after myeloablative conditioning and 37 patients received BM after myeloablative conditioning. In the nonmyeloablative group, the NK cells normalised after 1 month, the CD8+ T cells normalised after 3 months, the CD4+ T cells reached near normal values after 9 months and the B cell values were reduced until 12 months after transplant. In the two myeloablative groups, recipients of PBSC had a significantly higher number of CD4+ T cells after 4 months (P=0.004) and after 12 months (P=0.001), than recipients of BM. We found no differences in the T cell reconstitution between the two PBSC groups. This was of interest as the recipients of nonmyeloablative conditioning were older (P<0.001) and had a higher occurrence of chronic GVHD (P<0.05) than the recipients of myeloablative conditioning. In contrast, the recipients of nonmyeloablative conditioning had a delayed B cell recovery when compared to the patients who received myeloablative conditioning (P=0.04).
KW - Adolescent
KW - Adult
KW - B-Lymphocytes/physiology
KW - Bone Marrow Transplantation/methods
KW - Female
KW - Graft Survival
KW - Graft vs Host Disease/chemically induced
KW - Hematologic Neoplasms/therapy
KW - Histocompatibility Testing
KW - Humans
KW - Killer Cells, Natural/physiology
KW - Lymphopoiesis
KW - Male
KW - Middle Aged
KW - Peripheral Blood Stem Cell Transplantation/methods
KW - Regression Analysis
KW - Retrospective Studies
KW - Siblings
KW - T-Lymphocytes/physiology
KW - Transplantation Conditioning/methods
KW - Transplantation, Homologous
KW - Transplantation, Isogeneic
U2 - 10.1038/sj.bmt.1704084
DO - 10.1038/sj.bmt.1704084
M3 - Journal article
C2 - 12815480
SN - 0268-3369
VL - 32
SP - 65
EP - 72
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 1
ER -